Novel Therapeutics Company Forms Strategic Collaboration Agreement
DURECT Corporation and Charles River Laboratories: A Strategic Alliance Set to Revolutionize the Biopharmaceutical Industry.
In a significant move within the biopharmaceutical industry,DURECT Corporation (DRRX)has entered into a co-marketing and collaboration agreement with Charles River Laboratories International, Inc. This alliance, announced on March 4, 2024, is set to jointly market and commercialize the ALZET Osmotic Pumps Portfolio and Associated Product Line in the United States and Canada.$Durect (DRRX.US)$